APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non - Laboratory - based Cannabis Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non - Laboratory - based Cannabis Testing Market Outlook and Growth Opportunities 2026

6 June 2026196 pages

Choose your research edition.

Industry ResearchNon - Laboratory - based Cannabis Testing Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Non - Laboratory - based Cannabis Testing Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Non - Laboratory - based Cannabis Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non - Laboratory - based Cannabis Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Non - Laboratory - based Cannabis Testing Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Non - Laboratory - based Cannabis Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non - Laboratory - based Cannabis Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non - Laboratory - based Cannabis Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non - Laboratory - based Cannabis Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non - Laboratory - based Cannabis Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non - Laboratory - based Cannabis Testing market include Purpl Scientific, Orange Photonics, Inc., MyDx, Inc., tCheck, ALPHA—CAT and Sage Analytics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non - Laboratory - based Cannabis Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non - Laboratory - based Cannabis Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non - Laboratory - based Cannabis Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non - Laboratory - based Cannabis Testing market.

Non - Laboratory - based Cannabis Testing Segment by Company

Purpl Scientific

Orange Photonics, Inc.

MyDx, Inc.

tCheck

ALPHA—CAT

Sage Analytics, Inc.

Non - Laboratory - based Cannabis Testing Segment by Type

Chromatography

Spectroscopy

Others

Non - Laboratory - based Cannabis Testing Segment by Application

Recreation

Agriculture

Others

Non - Laboratory - based Cannabis Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non - Laboratory - based Cannabis Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non - Laboratory - based Cannabis Testing key companies, revenue, market share, and recent developments.

3. To split the Non - Laboratory - based Cannabis Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non - Laboratory - based Cannabis Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non - Laboratory - based Cannabis Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Non - Laboratory - based Cannabis Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non - Laboratory - based Cannabis Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non - Laboratory - based Cannabis Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non - Laboratory - based Cannabis Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non - Laboratory - based Cannabis Testing industry.

Chapter 3: Detailed analysis of Non - Laboratory - based Cannabis Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non - Laboratory - based Cannabis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non - Laboratory - based Cannabis Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non - Laboratory - based Cannabis Testing Industry Trends Table 2. Non - Laboratory - based Cannabis Testing Industry Drivers Table 3. Non - Laboratory - based Cannabis Testing Industry Opportunities and Challenges Table 4. Non - Laboratory - based Cannabis Testing Industry Restraints Table 5. Global Non - Laboratory - based Cannabis Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non - Laboratory - based Cannabis Testing Revenue Share by Company (2021-2026) Table 7. Global Non - Laboratory - based Cannabis Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non - Laboratory - based Cannabis Testing Key Company Manufacturing Base & Headquarters Table 9. Global Non - Laboratory - based Cannabis Testing Company, Product Type & Application Table 10. Global Non - Laboratory - based Cannabis Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non - Laboratory - based Cannabis Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chromatography Table 15. Significant Companies of Spectroscopy Table 16. Significant Companies of Others Table 17. Global Non - Laboratory - based Cannabis Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Non - Laboratory - based Cannabis Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Non - Laboratory - based Cannabis Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Type (2021-2026) Table 21. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Recreation Table 23. Significant Companies of Agriculture Table 24. Significant Companies of Others Table 25. Global Non - Laboratory - based Cannabis Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Non - Laboratory - based Cannabis Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Non - Laboratory - based Cannabis Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Application (2021-2026) Table 29. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Application (2027-2032) Table 30. Global Non - Laboratory - based Cannabis Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Non - Laboratory - based Cannabis Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Region (2021-2026) Table 33. Global Non - Laboratory - based Cannabis Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Region (2027-2032) Table 35. Global Non - Laboratory - based Cannabis Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Non - Laboratory - based Cannabis Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Non - Laboratory - based Cannabis Testing Sales Value Market Share by Country (2021-2026) Table 38. Global Non - Laboratory - based Cannabis Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Non - Laboratory - based Cannabis Testing Sales Value Market Share by Country (2027-2032) Table 40. Purpl Scientific Company Information Table 41. Purpl Scientific Business Overview Table 42. Purpl Scientific Non - Laboratory - based Cannabis Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Purpl Scientific Non - Laboratory - based Cannabis Testing Product Portfolio Table 44. Purpl Scientific Recent Development Table 45. Orange Photonics, Inc. Company Information Table 46. Orange Photonics, Inc. Business Overview Table 47. Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio Table 49. Orange Photonics, Inc. Recent Development Table 50. MyDx, Inc. Company Information Table 51. MyDx, Inc. Business Overview Table 52. MyDx, Inc. Non - Laboratory - based Cannabis Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. MyDx, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio Table 54. MyDx, Inc. Recent Development Table 55. tCheck Company Information Table 56. tCheck Business Overview Table 57. tCheck Non - Laboratory - based Cannabis Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. tCheck Non - Laboratory - based Cannabis Testing Product Portfolio Table 59. tCheck Recent Development Table 60. ALPHA—CAT Company Information Table 61. ALPHA—CAT Business Overview Table 62. ALPHA—CAT Non - Laboratory - based Cannabis Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. ALPHA—CAT Non - Laboratory - based Cannabis Testing Product Portfolio Table 64. ALPHA—CAT Recent Development Table 65. Sage Analytics, Inc. Company Information Table 66. Sage Analytics, Inc. Business Overview Table 67. Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio Table 69. Sage Analytics, Inc. Recent Development Table 70. Research Programs/Design for This Report Table 71. Authors List of This Report Table 72. Secondary Sources Table 73. Primary Sources List of Figures Figure 1. Non - Laboratory - based Cannabis Testing Product Image Figure 2. Global Non - Laboratory - based Cannabis Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non - Laboratory - based Cannabis Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Non - Laboratory - based Cannabis Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chromatography Image Figure 8. Spectroscopy Image Figure 9. Others Image Figure 10. Global Non - Laboratory - based Cannabis Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Non - Laboratory - based Cannabis Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Type (2021-2032) Figure 13. Recreation Image Figure 14. Agriculture Image Figure 15. Others Image Figure 16. Global Non - Laboratory - based Cannabis Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Non - Laboratory - based Cannabis Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Application (2021-2032) Figure 19. Global Non - Laboratory - based Cannabis Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Non - Laboratory - based Cannabis Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Non - Laboratory - based Cannabis Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America Non - Laboratory - based Cannabis Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Non - Laboratory - based Cannabis Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Non - Laboratory - based Cannabis Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Non - Laboratory - based Cannabis Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Non - Laboratory - based Cannabis Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Non - Laboratory - based Cannabis Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America Non - Laboratory - based Cannabis Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Non - Laboratory - based Cannabis Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Non - Laboratory - based Cannabis Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Chromatography
  • Spectroscopy
  • Others
Applications
  • Recreation
  • Agriculture
  • Others
Companies covered
  • Purpl Scientific
  • Orange Photonics, Inc.
  • MyDx, Inc.
  • tCheck
  • ALPHA—CAT
  • Sage Analytics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non - Laboratory - based Cannabis Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non - Laboratory - based Cannabis Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non - Laboratory - based Cannabis Testing Market Dynamics
  1. 2.1 Non - Laboratory - based Cannabis Testing Industry Trends
  2. 2.2 Non - Laboratory - based Cannabis Testing Industry Drivers
  3. 2.3 Non - Laboratory - based Cannabis Testing Industry Opportunities and Challenges
  4. 2.4 Non - Laboratory - based Cannabis Testing Industry Restraints
3 Non - Laboratory - based Cannabis Testing Market by Company
  1. 3.1 Global Non - Laboratory - based Cannabis Testing Company Revenue Ranking in 2025
  2. 3.2 Global Non - Laboratory - based Cannabis Testing Revenue by Company (2021-2026)
  3. 3.3 Global Non - Laboratory - based Cannabis Testing Company Ranking (2024-2026)
  4. 3.4 Global Non - Laboratory - based Cannabis Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Non - Laboratory - based Cannabis Testing Company Product Type and Application
  6. 3.6 Global Non - Laboratory - based Cannabis Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non - Laboratory - based Cannabis Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non - Laboratory - based Cannabis Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non - Laboratory - based Cannabis Testing Market by Type
  1. 4.1 Non - Laboratory - based Cannabis Testing Type Introduction
  2. 4.1.1 Chromatography
  3. 4.1.2 Spectroscopy
  4. 4.1.3 Others
  5. 4.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Type
  6. 4.2.1 Global Non - Laboratory - based Cannabis Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Non - Laboratory - based Cannabis Testing Sales Value Share by Type (2021-2032)
5 Non - Laboratory - based Cannabis Testing Market by Application
  1. 5.1 Non - Laboratory - based Cannabis Testing Application Introduction
  2. 5.1.1 Recreation
  3. 5.1.2 Agriculture
  4. 5.1.3 Others
  5. 5.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Application
  6. 5.2.1 Global Non - Laboratory - based Cannabis Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Non - Laboratory - based Cannabis Testing Sales Value Share by Application (2021-2032)
6 Non - Laboratory - based Cannabis Testing Regional Value Analysis
  1. 6.1 Global Non - Laboratory - based Cannabis Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non - Laboratory - based Cannabis Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non - Laboratory - based Cannabis Testing Sales Value (2021-2032)
  7. 6.3.2 North America Non - Laboratory - based Cannabis Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non - Laboratory - based Cannabis Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Non - Laboratory - based Cannabis Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non - Laboratory - based Cannabis Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non - Laboratory - based Cannabis Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non - Laboratory - based Cannabis Testing Sales Value (2021-2032)
  16. 6.6.2 South America Non - Laboratory - based Cannabis Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non - Laboratory - based Cannabis Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non - Laboratory - based Cannabis Testing Sales Value Share by Country, 2025 VS 2032
7 Non - Laboratory - based Cannabis Testing Country-level Value Analysis
  1. 7.1 Global Non - Laboratory - based Cannabis Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non - Laboratory - based Cannabis Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non - Laboratory - based Cannabis Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non - Laboratory - based Cannabis Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non - Laboratory - based Cannabis Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non - Laboratory - based Cannabis Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Purpl Scientific
  2. 8.1.1 Purpl Scientific Company Information
  3. 8.1.2 Purpl Scientific Business Overview
  4. 8.1.3 Purpl Scientific Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Purpl Scientific Non - Laboratory - based Cannabis Testing Product Portfolio
  6. 8.1.5 Purpl Scientific Recent Developments
  7. 8.2 Orange Photonics, Inc.
  8. 8.2.1 Orange Photonics, Inc. Company Information
  9. 8.2.2 Orange Photonics, Inc. Business Overview
  10. 8.2.3 Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio
  12. 8.2.5 Orange Photonics, Inc. Recent Developments
  13. 8.3 MyDx, Inc.
  14. 8.3.1 MyDx, Inc. Company Information
  15. 8.3.2 MyDx, Inc. Business Overview
  16. 8.3.3 MyDx, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MyDx, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio
  18. 8.3.5 MyDx, Inc. Recent Developments
  19. 8.4 tCheck
  20. 8.4.1 tCheck Company Information
  21. 8.4.2 tCheck Business Overview
  22. 8.4.3 tCheck Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 tCheck Non - Laboratory - based Cannabis Testing Product Portfolio
  24. 8.4.5 tCheck Recent Developments
  25. 8.5 ALPHA—CAT
  26. 8.5.1 ALPHA—CAT Company Information
  27. 8.5.2 ALPHA—CAT Business Overview
  28. 8.5.3 ALPHA—CAT Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ALPHA—CAT Non - Laboratory - based Cannabis Testing Product Portfolio
  30. 8.5.5 ALPHA—CAT Recent Developments
  31. 8.6 Sage Analytics, Inc.
  32. 8.6.1 Sage Analytics, Inc. Company Information
  33. 8.6.2 Sage Analytics, Inc. Business Overview
  34. 8.6.3 Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio
  36. 8.6.5 Sage Analytics, Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst